SCHEMBL8420764

SCHEMBL8420764

CN1C(=O)c2cccnc2Cc2ncccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.43
CES1 P23141 1/20 0.43
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
BRD4 O60885 9/20 0.39
ALDH1A1 P00352 2/20 0.37
DRD2 P14416 2/20 0.37
HTR6 P50406 2/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CASP3 P42574 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
HTR1A P08908 1/20 0.36
HTR2A P28223 1/20 0.36
HTR7 P34969 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099507 0.82 ADORA3 (0.37) SMN1; SMN2ADORA3ADORA2AADORA1HTR1A
SCHEMBL8417601 0.82 TTR (0.36) TTRCES1NPC1TP53MAPT
SCHEMBL12060497 0.80 BRPF1 (0.43) BRD4ALDH1A1HTTADORA3ADORA2A
SCHEMBL8790761 0.73 TTR (0.50) TTRCES1BRD4ALDH1A1DRD2
SCHEMBL24440815 0.73 ADORA3 (0.33) ADORA3ADORA2AADORA1HTR1AHTR2A
SCHEMBL12059732 0.73 NPC1 (0.51) CES1NPC1TP53MAPTRAB9A
SCHEMBL8304689 0.72 ALDH1A1 (0.52) TTRCES1NPC1MAPTRAB9A
SCHEMBL585349 0.72 TDP1 (0.42) CES1TP53MAPTSMN1; SMN2ALDH1A1
SCHEMBL27027255 0.71 HTR2C (0.42) SMN1; SMN2DRD2HTR1AHTR2AHTR7
SCHEMBL18635357 0.71 CYP11B2 (0.44) DRD2ADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908841-A 5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e!azepine-6-ones and their use in the prevention of treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-06-01 US disclosed